# Trade Mark Journal No.2026/013 27 March 2026

## WO0000001906172 (5)

Office of origin: United States of America

Date of International Registration:30 October 2025
Date of designation in the UK: 30 October 2025

International priority date claimed: 30 April 2025 (United States of America) (99163806)

Class 5
  Pharmaceutical preparations for the treatment of cancer, pain, infection, inflammation, hormone disorders, bone disorders, and mental disorders; analgesics; hormones for medical purposes; psychotropics; anti-infectives; anti-inflammatories; anti-cancer preparations.

Azurity Pharmaceuticals, Inc.

Representative: Douglas R. Wolf Wolf Greenfield & Sacks, P.C., 600 Atlantic Avenue, Boston MA 02210, UNITED STATES OF AMERICA